Biomaterials as signal-releasing platforms
IBEC’s Biomaterials for Regenerative Therapies group has published a review of the state-of-the-art in biomaterials for skin healing that proposes a move towards more personalized, in situ therapies.
IBEC’s Biomaterials for Regenerative Therapies group has published a review of the state-of-the-art in biomaterials for skin healing that proposes a move towards more personalized, in situ therapies.Skin wound healing repairs and restore tissue through a complex process that involves different cells and signalling molecules that regulate cellular response and the remodelling of the extracellular matrix. Publishing in Advanced Drug Delivery Reviews, the article begins by summarizing recent advances in therapies for healing that combine biomolecule signals such as growth factors and cytokines with cells.
A ‘Results in Brief’ article about Elena Martinez’s ERC project COMIET has been published on the CORDIS website, the EC’s Community Research and Development Information Service.
Joan Montero, a senior researcher in IBEC’s Nanobioengineering group, appeared yesterday in an interview published by the SINC Agency in which he talks about his laboratory test – which is already being used in some hospitals in the United States – which is capable of predicting, in just 24 hours, if a drug will be able to kill a tumor.
Last month IBEC Director Josep Samitier was one of the panelists in a round table organised by the Cercle de Salut, an association devoted to improving the health system so that it may respond adequately to the challenges posed by society.
IBEC’s Smart-Nano-Bio-Devices and Nanobioengineering groups have joined forces to solve the problem of random movement of micro- and nanomotors.